Opportunity Information: Apply for PAR 20 311
The NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 - Clinical Trial Not Allowed), funding opportunity number PAR-20-311, is an NIH discretionary grant program designed to strengthen the pipeline of physician-scientists in neurology and stroke-related fields. Run under the NIH Research Education Program (R25) mechanism, it focuses on building high-quality research education experiences that complement clinical training and help meet national biomedical, behavioral, and clinical research workforce needs. The central idea is to give residents and fellows structured, mentored research exposure that moves them beyond simply learning about research and toward actually developing as independent investigators in areas aligned with the NINDS mission, such as understanding disease mechanisms, causes (etiology), and treatments for neurological disorders.
A defining feature of this program is its emphasis on hands-on research experiences as the primary educational activity. Programs supported through this FOA are expected to create thoughtful, well-mentored research opportunities that fit the realities of residency and fellowship schedules while still being rigorous enough to produce meaningful scholarly development. The goal is not only to help clinicians participate in research during training, but to position them to successfully compete for the next major step in a research career, particularly NIH mentored career development awards (for example, K-series awards), and in some cases to set the stage for competing for independent research funding later on. In other words, the R25 is intended to be a bridge from clinical training into a sustained physician-scientist trajectory, with research skill-building, mentorship, and professional development intentionally built into the program design.
The FOA also includes a cohort-building and accountability component through an annual workshop requirement. Participants supported by the R25 are expected to attend and participate in an annual, FOA-specific workshop where they present their work, discuss progress, and outline plans for transitioning to the next career stage. This workshop is also meant to create networking opportunities with peers, established researchers, and leaders in relevant disciplines. That recurring touchpoint is designed to keep trainees moving forward, make career planning more concrete, and reduce the drop-off that often happens when clinicians finish residency or fellowship without a clear runway into funded research.
As indicated by the title, clinical trials are not allowed under this opportunity. That means proposed activities should not include conducting clinical trials as defined by NIH policy. The supported work should remain within allowable research education and research experience activities that do not cross into running clinical trials, even if the broader program is clinically oriented. Applicants typically need to plan research experiences and mentoring that are compatible with this restriction and clearly describe how participant activities will comply.
Eligibility to apply is broad across U.S.-based organizations involved in training and research. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations other than small businesses, small businesses, and other qualifying organizations. The announcement explicitly highlights additional eligible applicant types that include several categories of institutions that serve populations underrepresented in biomedical research, such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). At the same time, foreign participation is restricted: non-U.S. (non-domestic) entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed.
Administratively, this opportunity is offered by the National Institutes of Health under the NINDS mission area, with CFDA number 93.853 and a grant funding instrument type. The original closing date listed for the opportunity was January 25, 2023, and the FOA was created on October 27, 2020. While the excerpt does not specify an award ceiling or expected number of awards, the program’s intent is clear: to fund robust, creative research education programs that help residents and fellows become competitive, well-mentored, research-capable clinicians who remain in the biomedical research workforce and contribute to advances in neurological disorders and stroke.Apply for PAR 20 311
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853.
- This funding opportunity was created on 2020-10-27.
- Applicants must submit their applications by 2023-01-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education, Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Previous opportunity: Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 20 311
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 20 311) also looked into and applied for these:
| Funding Opportunity |
|---|
| Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) Apply for PAR 21 040 Funding Number: PAR 21 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Treatments for Lewy Body Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) Apply for RFA NS 21 008 Funding Number: RFA NS 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 - Clinical Trial Not Allowed) Apply for RFA GM 21 001 Funding Number: RFA GM 21 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional) Apply for RFA MD 21 001 Funding Number: RFA MD 21 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 21 007 Funding Number: RFA RM 21 007 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) Apply for RFA MD 21 002 Funding Number: RFA MD 21 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed) Apply for PAR 21 077 Funding Number: PAR 21 077 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 21 036 Funding Number: PAR 21 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) Apply for PAR 21 045 Funding Number: PAR 21 045 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) Apply for RFA MH 21 112 Funding Number: RFA MH 21 112 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAAA Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 21 072 Funding Number: PAR 21 072 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) Apply for PAR 21 053 Funding Number: PAR 21 053 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) Apply for RFA MH 21 111 Funding Number: RFA MH 21 111 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) Apply for RFA MH 21 110 Funding Number: RFA MH 21 110 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) Apply for RFA MH 21 160 Funding Number: RFA MH 21 160 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) Apply for PAR 21 043 Funding Number: PAR 21 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) Apply for RFA MH 21 105 Funding Number: RFA MH 21 105 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required) Apply for PAR 21 041 Funding Number: PAR 21 041 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) Apply for PAR 21 079 Funding Number: PAR 21 079 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) Apply for PAR 21 042 Funding Number: PAR 21 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 311", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
